Treatment strategy | Comparator | Odds ratio | Standard error | 95% Confidence interval | |
---|---|---|---|---|---|
Infliximab | Placebo | 1.36 | 0.45 | 0.57 | 3.27 |
Adalimumab | Placebo | 0.77 | 0.36 | 0.38 | 1.56 |
Certolizumab pegol | Placebo | 2.37 | 0.50 | 0.88 | 6.38 |
Natalizumab | Placebo | 0.80 | 0.40 | 0.37 | 1.73 |
Ustekinumab | Placebo | 0.40 | 0.49 | 0.16 | 1.05 |
Vedolizumab | Placebo | 0.75 | 0.38 | 0.36 | 1.58 |
Golimumab | Placebo | 1.71 | 0.67 | 0.46 | 6.31 |
Methotrexate | Placebo | 0.52 | 1.28 | 0.04 | 6.34 |
Azathioprine/6MP | Placebo | 1.43 | 0.61 | 0.43 | 4.76 |
Prednisone | Placebo | 1.92 | 0.85 | 0.36 | 10.21 |
Budesonide | Placebo | 1.99 | 1.65 | 0.08 | 50.97 |
Aminosalicylate | Placebo | 1.37 | 1.40 | 0.09 | 21.47 |
Antibiotic | Placebo | 1.01 | 1.07 | 0.12 | 8.34 |
Tacrolimus | Placebo | 1.19 | 2.02 | 0.02 | 62.32 |
Methotrexate + prednisone | Placebo | 2.94 | 1.45 | 0.17 | 50.23 |
Azathioprine/6MP + prednisone | Placebo | 2.37 | 1.76 | 0.07 | 75.25 |
Aminosalicylate + prednisone | Placebo | 7.32 | 2.41 | 0.06 | 832.34 |
Budesonide + prednisone | Placebo | 1.89 | 2.18 | 0.03 | 135.88 |
MMF + prednisone | Placebo | 4.14 | 2.07 | 0.07 | 241.50 |
Infliximab + azathioprine/6MP | Placebo | 1.10 | 0.65 | 0.31 | 3.97 |
Azathioprine/6MP + aminosalicylate | Placebo | 1.35 | 2.11 | 0.02 | 83.66 |
Natalizumab + inflximab | Placebo | 0.71 | 2.06 | 0.01 | 40.65 |
Infliximab + azathioprine/6MP + prednisone | Placebo | 0.32 | 2.33 | 0.00 | 30.40 |